Publications

August 2001
Case

Scios, Inc.

By: Regina E. Herzlinger

Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Cost Management; Cost vs Benefits; Social Issues; Pharmaceutical Industry; United States

Program

Program for Leadership Development

the careful selection of living group members and new HBS case studies to professional executive coaching for individuals and teams, every aspect is designed to foster collaborative learning and accelerate personal growth. Review Our... View Details

07 Apr 2020
News

How to Manage Coronavirus Layoffs with Compassion

June 2008
Case

Treadway Tire Company: Job Dissatisfaction and High Turnover at the Lima Plant

By: C. Wickham Skinner and Heather Beckham

Treadway Tire's plant in Lima, Ohio must confront strong job dissatisfaction and high turnover among its line foremen. The foremen are caught in the middle of an adversarial relationship between the union and management, and they must cope with the needs and interests... View Details

Keywords: Superior ＆ Subordinate; Labor Relations; Work Force Management; Human Resource Management; Hiring; Job Satisfaction; Management; Leadership; Retention; Rank and Position; Organizational Culture; Change Management; Selection and Staffing; Satisfaction; Personal Development and Career; Labor and Management Relations; Manufacturing Industry; Auto Industry; Ohio

August 8, 2018
Article

Hospital-based ACOs Face Challenges in Tracking Performance Indicators

By: Christiana Beveridge, Sofia Warner, Greg Leya and Thomas W. Feeley

Given that accountable care organizations (ACOs) have not achieved the degree of cost reductions and quality improvements initially hoped for, we sought to better understand the underlying reasons for their limited success. Our analysis of American Hospital Association... View Details

Keywords: ACOs; Health Care and Treatment; Cost Management; Performance; Measurement and Metrics

Read Now

March 2018
Article

Polluted Morality: Air Pollution Predicts Criminal Activity and Unethical Behavior

By: Jackson G. Lu, Julia J. Lee, F. Gino and Adam D. Galinsky

Air pollution is a serious problem that influences billions of people globally. Although the health and environmental costs of air pollution are well known, the present research investigates its ethical costs. We propose that air pollution can increase criminal and... View Details

Keywords: Pollutants; Behavior; Moral Sensibility; Crime and Corruption

Find at Harvard

Research Summary

Coordination, Control, and the Management of Organizations

Michael C. Jensen's research is aimed at obtaining a clearer understanding of how the 'organizational rules of the game' affect a manager's ability to accomplish his or her goals and how the rules can be structured to resolve problems and increase productivity. ... View Details

June 2014
Article

Improving Value with TDABC

By: Robert S. Kaplan

The article discusses the benefits of time-driven activity-based costing (TDABC) combined with outcomes measurement for healthcare organizations. Topics covered include improving resource efficiency, optimizing care over the complete care cycle, and planning and... View Details

Keywords: Goals and Objectives; Activity Based Costing and Management; Health Care and Treatment; Health Industry

Find at Harvard

09 Jun 2016
Blog Post

Pursuing an Interest in Nonprofits at HBS

There are a number of ways to pursue an interest in nonprofit organizations while at HBS. I have personally explored this interest through joining the Board Fellows and Social Enterprise Consulting Club, undertaking an Independent... View Details

December 2005 (Revised August 2006)
Case

Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug

By: Felix Oberholzer-Gee and Dennis A. Yao

Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details

Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States

November 2013 (Revised November 2014)
Case

Infection Control at Massachusetts General Hospital

By: Robert S. Huckman and Nikolaos Trichakis

The case explores the challenges facing Massachusetts General Hospital concerning the adoption of a new infection control policy, which promises to improve operational performance, patient safety, and profitability. The new policy requires coordination between... View Details

Keywords: Safety; Organizational Change and Adaptation; Integration; Health Care and Treatment; Policy; Health Industry; Boston

July 2001 (Revised August 2005)
Case

Medicines Company, The

By: John T. Gourville

It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The... View Details

Keywords: Business Model; Change Management; Decision Choices and Conditions; Cost Management; Price; Product Marketing; Product Launch; Product Development; Risk and Uncertainty; Health Industry; Health Industry

28 Jan 2014
First Look

First Look: January 28

After an overview of Boston Children's Hospital and its local health care market environment, the case presents process maps and financial data relating to patients making office visits to a plastic surgeon for three different diagnoses.... View Details

Keywords: Sean Silverthorne

September 2019
Case

Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem

By: Willy C. Shih

Vaccines for children has been a long-standing focus for the Bill & Melinda Gates Foundation, and its critical role in public health made its production an important economic and political issue. This case describes the Foundation's investment in a breakthrough vaccine... View Details

Keywords: Vaccine; Production; Supply Chain; Product; Biotechnology Industry; Pharmaceutical Industry; Manufacturing Industry; Belgium